Screening patients with rheumatoid arthritis for lung disease
Official title: Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease With Radiographic and Labor Methods
Run by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest · NCT05391100 · Data updated 2026-11-12
This study is trying to see if people with rheumatoid arthritis in Hungary have lung problems by using tests and questionnaires to check their lung health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Polyclinic of the Hospitaller Brothers of St. John of God, Budapest Academic / other |
| Locations | 3 sites (Budapest and 2 other locations) |
| Status | Recruiting |
| Started | February 1, 2022 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | May 31, 2022 |
| Trial ID | NCT05391100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with rheumatoid arthritis.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have a previous diagnosis of interstitial lung disease, lung cancer, or a registered lung infection in the last two months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess interstitial lung involvement in Hungarian patients diagnosed with rheumatoid arthritis (RA). It employs a combination of laboratory markers, X-ray imaging, pulmonary function tests, and quality of life questionnaires to evaluate the presence and severity of interstitial lung disease (ILD). Additionally, the study plans to create a national register based on the collected data and conduct smaller cross-sectional studies focusing on imaging parameters.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of interstitial lung disease in patients with rheumatoid arthritis.
How similar studies have gone: While there have been studies on lung involvement in rheumatoid arthritis, this specific approach focusing on the Hungarian population and creating a national register is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of RA Exclusion Criteria: * pregnancy, breastfeeding * previous diagnosis of ILD, lung cancer, registered lung infection in the last 2 months
Where it's running
-
Buda Hospital of the Hospitaller Order of Saint John of God
Budapest, Hungary Recruiting -
Medical Imaging Centre, Semmelweis University
Budapest, Hungary Recruiting -
Department of Pulmonology, Semmelweis University Faculty of Medicine
Budapest, Hungary Recruiting
Study contacts
- Principal investigator: Judit Majnik, MD PhD
- Study coordinator: Kinga Fritsch, MD
- Email: kflinta@hotmail.com
- Phone: +36302892319
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inspiratory muscle training added to pulmonary rehabilitation for people with RA-related interstitial lung disease
This project will test whether adding inspiratory muscle training to standard pulmonary rehabilitation helps people with rheumatoid arthritis-associated interstitial lung disease breathe easier, walk farther, gain muscle strength, feel better psychologically, and change levels of certain long noncoding RNAs.
-
Identifying high-risk patients with lung disease related to rheumatoid arthritis
This study is trying to find out which patients with lung disease related to rheumatoid arthritis are at the highest risk of their condition getting worse.
-
Using lung ultrasound to detect lung disease in rheumatoid arthritis patients
This study is testing if lung ultrasound can help find lung disease in people with rheumatoid arthritis who have certain risk factors, comparing it to the usual chest CT scans.
-
Identifying lung disease risks in rheumatoid arthritis patients
This study is trying to find out how lung disease develops in people with rheumatoid arthritis and what signs can help doctors catch it early.
-
GenAI-assisted RA bone erosion risk and DMARD choice
This study tests whether GenAI-based decision support can help doctors assess rheumatoid arthritis bone erosion risk and pick DMARDs for newly diagnosed inpatients.
-
Telitacicept for primary Sjögren’s with interstitial lung disease
This study tests whether Telitacicept helps people with primary Sjögren’s syndrome and interstitial lung disease compared with standard immunosuppressants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.